MTND2P18

Across TCGA pan-cancer cohorts, MTND2P18 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MTND2P18 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MTND2P18 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTND2P18 expression acts as an unfavorable survival marker, although some lineages such as STAD and KICH show a favorable association.

UCEC, LUAD, and CESC are the cancer types where MTND2P18 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.579	0.846	<.001	60	view →
LUAD	OS	Tertile	II,III,IV	0.308	0.567	.013	45	view →
CESC	DFS	Tertile	III,IV	0.231	0.737	.002	36	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
STAD	OS	Tertile	IV	0.805	0.283	.031	18	view →
READ	DFS	Tertile	IV	0.082	0.619	.001	18	view →
BRCA	DFS	Tertile	All	0.463	0.532	.046	6	view →
ESCA	OS	Quartile	II,III,IV	0.285	0.589	.038	3	view →
KICH	DFS	Tertile	II,III,IV	1.000	0.681	.040	3	view →
LGG	OS	Tertile	All	0.833	0.479	.019	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MTND2P18–UCEC (DFS)

Open the UCEC breakdown →